healthliberal
Risk of Ovarian Cancer in Women with Endometriosis
Sunday, May 17, 2026
- Double the risk: Women with endometriosis, especially those with ovarian cysts called endometriomas, face about twice the chance of developing ovarian cancer compared to those without the condition.
- Lifetime risk: Still small—roughly 2 percent overall.
Shared Genetic Mutations
Studies reveal that the same gene alterations—ARID1A, PIK3CA, and KRAS—can appear in both endometriosis lesions and certain ovarian cancers. The hostile environment inside an endometrioma may help these changes evolve into cancer, but it is not a guarantee.
Detection Challenges
- Imaging: Ultrasounds and MRI scans are the primary tools for spotting endometriosis, yet they do not reliably detect when a cyst becomes cancerous.
- Blood markers: Tests for CA‑125 and HE4 provide extra clues but are not precise enough to replace imaging.
Prevention Strategies
| Strategy | Effectiveness | Considerations |
|---|---|---|
| Combined Oral Contraceptives (COCs) | Lowers ovarian cancer risk; protective effect can last >10 years after stopping. Also reduces risks of endometrial and colorectal cancers. | Requires long‑term use; not a cure. |
| Surgical removal of ovarian cysts | Lowers cancer risk but may reduce ovarian reserve and increase recurrence. | Important for younger women prioritizing fertility. |
| Risk‑reducing salpingo-oophorectomy | Recommended for women with inherited cancer genes. Not routine for all endometriosis patients. | Permanently stops ovarian function. |
Emerging Research
- Personalized risk calculators: Combining genetic data, medical history, and lifestyle choices to predict individual cancer risk.
- Long‑term outcomes: Ongoing studies will clarify whether preserving cysts or removing them yields better cancer prevention and survival.
Managing Endometriosis
Effective care involves a multidisciplinary team to balance:
- Cancer protection
- Fertility goals
- Overall well‑being
Actions
flag content
